{"id":27946,"date":"2020-03-19T19:08:22","date_gmt":"2020-03-20T01:08:22","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=27946"},"modified":"2020-03-20T07:03:56","modified_gmt":"2020-03-20T13:03:56","slug":"animal-health-news-notes-for-march-20-2020","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-march-20-2020\/","title":{"rendered":"Not\u00edcias e notas de sa\u00fade animal de 20 de mar\u00e7o de 2020"},"content":{"rendered":"<p>***********************************<br \/>\n<strong>Brakke Consulting&#039;s <\/strong><br \/>\n<strong>Not\u00edcias e notas de sa\u00fade animal de 20 de mar\u00e7o<\/strong><strong>, 2020<\/strong><br \/>\n<em>Copyright \u00a9 Brakke Consulting<br \/>\n<\/em><em>Editor: Lynn Fondon DVM MBA<br \/>\n<\/em>************************************<\/p>\n<p>NAS NOTICIAS:<\/p>\n<p><u>Not\u00edcias da Brakke Consulting<\/u><br \/>\npesquisa de mercado<\/p>\n<p><u>Not\u00edcias de Ganhos<br \/>\n<\/u>Bioci\u00eancias afins<\/p>\n<p><u>Outras not\u00edcias<br \/>\n<\/u>BabelBark<br \/>\nDechra<br \/>\nanimal de estima\u00e7\u00e3o de destino<br \/>\nBioci\u00eancias afins<br \/>\nGest\u00e3o de Investimentos Morgan Stanley<br \/>\nmar \u00f4mega<br \/>\nPathway Vet Alliance<strong><br \/>\n<\/strong>Spectrum Brands Pet<br \/>\nParceiros Consumidores TSG<br \/>\nVitalPet<br \/>\nbigodeDocs<strong><br \/>\n<\/strong><\/p>\n<p><strong>************************************<\/strong><\/p>\n<p><strong>RELEASES DE RESULTADOS DA EMPRESA<\/strong><\/p>\n<ul>\n<li><strong>Bioci\u00eancias afins<\/strong>, Inc. relatou resultados financeiros para o ano encerrado em 31 de dezembro de 2019. A receita l\u00edquida de produtos no ano de 2019 foi de $4,3 milh\u00f5es, em compara\u00e7\u00e3o com $2,0 milh\u00f5es no ano encerrado em 31 de dezembro de 2018. Em 31 de dezembro de 2019, A KindredBio tinha $73,5 milh\u00f5es em caixa, equivalentes de caixa e investimentos, em compara\u00e7\u00e3o com $73,9 milh\u00f5es em 31 de dezembro de 2018.<em> (comunicado de imprensa da empresa)<\/em><\/li>\n<\/ul>\n<p><strong>***********************************<\/strong><br \/>\n<strong>CONSULTORIA DE FREIO<\/strong><\/p>\n<p><strong>Insights oportunos por meio de pesquisas de mercado de retorno r\u00e1pido<\/strong><\/p>\n<p>Com nosso banco de dados interno de veterin\u00e1rios e a capacidade de personalizar pesquisas de uma ampla variedade de p\u00fablicos-alvo, podemos fornecer informa\u00e7\u00f5es confi\u00e1veis sobre esse setor exclusivo e obter os resultados rapidamente. Para obter mais informa\u00e7\u00f5es, consulte nosso site ou ligue para 336-396-3916.<\/p>\n<p><a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a><\/p>\n<p><strong>************************************<\/strong><\/p>\n<p><strong>COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<\/strong><\/p>\n<ul>\n<li><strong>Bioci\u00eancias afins,<\/strong> anunciou que celebrou opera\u00e7\u00e3o de venda da Mirataz para <strong>Dechra Pharmaceuticals PLC <\/strong>por um pagamento inicial de $43 milh\u00f5es e royalties sobre vendas mundiais. A KindredBio registrou receita l\u00edquida de produtos de $4,1 milh\u00f5es para a Mirataz em 2019. Al\u00e9m disso, a empresa anunciou que reduzir\u00e1 substancialmente sua pegada comercial e se tornar\u00e1 uma empresa focada em produtos biol\u00f3gicos que busca os mercados canino e felino, enquanto descontinua o desenvolvimento de pequenas mol\u00e9culas para essas esp\u00e9cies; e os ativos equinos ser\u00e3o segregados na subsidi\u00e1ria KindredBio Equine.<em> (comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>Spectrum Brands Pet<\/strong>, LLC, anunciou a aquisi\u00e7\u00e3o de substancialmente todos os ativos da <strong>mar \u00f4mega <\/strong>LLC para adicionar ao seu portf\u00f3lio Global Pet Care de marcas aqu\u00e1ticas. A Omega Sea \u00e9 uma empresa global de nutri\u00e7\u00e3o aqu\u00e1tica que fabrica e comercializa produtos aliment\u00edcios premium para peixes, principalmente sob a marca Omega One. Os termos financeiros n\u00e3o foram divulgados. <em>(Ind\u00fastria de Alimentos para Animais de Estima\u00e7\u00e3o)<\/em><\/li>\n<li><strong>BabelBark <\/strong>e <strong>bigodeDocs<\/strong> anunciaram que fizeram uma parceria para garantir que todas as pr\u00e1ticas possam continuar a oferecer cuidados m\u00e9dicos cr\u00edticos e manter seus funcion\u00e1rios e donos de animais de estima\u00e7\u00e3o seguros, fornecendo linha direta de ajuda veterin\u00e1ria gratuita 24 horas por dia, 7 dias por semana para triagem. Este servi\u00e7o ajudar\u00e1 hospitais nos Estados Unidos e Canad\u00e1 a realizar avalia\u00e7\u00f5es de pacientes e continuar o atendimento veterin\u00e1rio remotamente, sem nenhum custo, pelos pr\u00f3ximos 60 dias. A BabelBark tamb\u00e9m est\u00e1 isentando taxas de seu servi\u00e7o de telessa\u00fade para simplificar ainda mais as comunica\u00e7\u00f5es entre os provedores de sa\u00fade para animais de estima\u00e7\u00e3o.<em> (comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>Gest\u00e3o de Investimentos Morgan Stanley<\/strong> anunciou que concordou em vender <strong>Pathway Vet Alliance LLC<\/strong> para <strong>Parceiros Consumidores TSG<\/strong>. Os termos financeiros n\u00e3o foram divulgados.<em> (Jornal de Wall Street)<\/em><\/li>\n<li><strong>animal de estima\u00e7\u00e3o de destino<\/strong> anunciou planos para adquirir <strong>VitalPet<\/strong>, que possui 24 hospitais veterin\u00e1rios atuando em sete estados, por um valor n\u00e3o divulgado. Uma ordem formal por escrito aprovando a venda foi arquivada no Tribunal de Fal\u00eancias dos Estados Unidos em Houston. <em>(Yahoo finan\u00e7as)<\/em><\/li>\n<\/ul>\n<p>***********************************<\/p>\n<p><strong>RASTREADOR DE PRE\u00c7O DE A\u00c7\u00d5ES DE SA\u00daDE ANIMAL<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-27958\" src=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.20-1.jpg\" alt=\"\" width=\"923\" height=\"665\" srcset=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.20-1.jpg 923w, https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.20-1-480x346.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 923px, 100vw\" \/><\/p>\n<p>*Pre\u00e7os de fechamento do mercado de quinta-feira<\/p>\n<p>***********************************<\/p>\n<p><strong>NOT\u00cdCIAS DE SA\u00daDE ANIMAL<\/strong><\/p>\n<ul>\n<li>EUA \u2013 REGULAMENTOS DE MEDICAMENTOS O Centro de Medicina Veterin\u00e1ria (CVM) da FDA anunciou sua decis\u00e3o de incluir produtos farmac\u00eauticos veterin\u00e1rios como parte do Acordo de Reconhecimento M\u00fatuo (ARM) FDA\/UE para Inspe\u00e7\u00f5es de Boas Pr\u00e1ticas de Fabrica\u00e7\u00e3o Farmac\u00eautica. A UE tamb\u00e9m concordou em princ\u00edpio em incluir medicamentos veterin\u00e1rios como parte do MRA.<em> (FDA)<\/em><\/li>\n<li>EUA \u2013 REGRAS DE IMPORTA\u00c7\u00c3O A FDA emitiu orienta\u00e7\u00f5es para comunicar a inten\u00e7\u00e3o da FDA de n\u00e3o aplicar temporariamente os requisitos de auditoria no local de verifica\u00e7\u00e3o de fornecedores para instala\u00e7\u00f5es de recebimento e importadores sob a Lei de Moderniza\u00e7\u00e3o da Seguran\u00e7a Alimentar da FDA (FSMA) em resposta \u00e0 pandemia global de COVID-19. A FDA n\u00e3o pretende aplicar os requisitos de auditoria no local se outros m\u00e9todos de verifica\u00e7\u00e3o do fornecedor forem usados. Para mais informa\u00e7\u00f5es, clique <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-issues-temporary-policy-fsma-onsite-audit-requirements\">aqui<\/a>. <em>(FDA)<br \/>\n<\/em><\/li>\n<li>EUA \u2013 INSPE\u00c7\u00d5ES DA FDA A FDA anunciou que adiou temporariamente todas as inspe\u00e7\u00f5es dom\u00e9sticas de rotina das instala\u00e7\u00f5es de vigil\u00e2ncia. Estas s\u00e3o inspe\u00e7\u00f5es de instala\u00e7\u00f5es que o FDA tradicionalmente realiza a cada poucos anos com base em uma an\u00e1lise de risco. \u00c9 importante ressaltar que todas as inspe\u00e7\u00f5es dom\u00e9sticas de justa causa ser\u00e3o avaliadas e prosseguir\u00e3o se forem cr\u00edticas. Continuaremos a responder a desastres naturais, surtos e outras emerg\u00eancias de sa\u00fade p\u00fablica envolvendo produtos regulamentados pela FDA.<em> (FDA)<\/em><\/li>\n<\/ul>\n<p>************************************<br \/>\n<strong>PONTO DE VISTA DA BRAKKE CONSULTORIA<\/strong><\/p>\n<p>Passamos tanto tempo sem esportes que voc\u00ea deve ter esquecido como \u00e9 ser um zagueiro nas manh\u00e3s de segunda-feira. Pessoalmente, passei a ser epidemiologista nas manh\u00e3s de segunda-feira. Felizmente, tenho as mesmas qualifica\u00e7\u00f5es educacionais em ci\u00eancia animal para ser um zagueiro e para ser um epidemiologista. Parece que usamos todo o manual para \u201cachatar a curva\u201d.<\/p>\n<p>Como epidemiologista iniciante, aprendi que as jogadas que estamos usando para combater o COVID-19 s\u00e3o baseadas em muitas suposi\u00e7\u00f5es importantes porque temos poucos dados confi\u00e1veis. (<a href=\"https:\/\/www.statnews.com\/2020\/03\/17\/a-fiasco-in-the-making-as-the-coronavirus-pandemic-takes-hold-we-are-making-decisions-without-reliable-data\/\">Aqui<\/a> \u2013 \u00e9 um \u00f3timo artigo sobre esse assunto.) Mas se voc\u00ea liderou neg\u00f3cios ou gerenciou pessoas ou produtos, \u00e0s vezes deve tomar decis\u00f5es sem dados confi\u00e1veis. N\u00e3o sabemos quanto tempo teremos que praticar o distanciamento social ou quanto tempo os representantes de vendas estacionar\u00e3o seus carros em casa. Ou quando escrit\u00f3rios ou escolas reabrir\u00e3o. Quando a vida voltar ao antigo normal.<\/p>\n<p>Mas voc\u00ea pode decidir agora tirar o melhor proveito de uma situa\u00e7\u00e3o ruim. Decida sair disso melhor do que voc\u00ea ou suas equipes antes de ouvirmos que achatar uma curva \u00e9 uma coisa boa. Os representantes de vendas de campo ainda podem ligar para seus clientes, o treinamento e o desenvolvimento ainda podem continuar, os planos de treinamento e desenvolvimento ainda podem ser trabalhados. Ou tente algo novo. Como Johan Wolfgang von Goethe (1749-1832) disse: \u201cUma nova atividade \u00e9 o \u00fanico meio de superar a adversidade\u201d.<\/p>\n<p><em>Bob Jones<\/em><\/p>\n<p>***********************************<\/p>\n<p><strong>SUA VIS\u00c3O<\/strong><\/p>\n<p>Na semana passada, perguntamos sobre os planos de conting\u00eancia COVID-19 da sua empresa. Mais de metade dos inquiridos afirmou: \u201cSim \u2013 Temos um plano de conting\u00eancia e j\u00e1 tom\u00e1mos medidas\u201d e cerca de um quarto disse: \u201cSim \u2013 Temos um plano de conting\u00eancia mas ainda n\u00e3o o pusemos em pr\u00e1tica\u201d. Sobre 15% triste n\u00e3o ou ainda n\u00e3o, ent\u00e3o parece que as empresas representadas em nossa pesquisa estavam prontas com um plano.<\/p>\n<p>Mais uma vez, continuando com o tema do coronav\u00edrus, para esta semana vamos prever o futuro ouvindo sua resposta a esta pergunta. (N\u00e3o se preocupe, suas respostas s\u00e3o realmente an\u00f4nimas, ent\u00e3o n\u00e3o podemos contar ao seu chefe.)<\/p>\n<p>Queremos ouvir voc\u00ea - compartilhe suas opini\u00f5es conosco nesta enquete de uma pergunta clicando abaixo!<\/p>\n<p><a href=\"https:\/\/www.surveymonkey.com\/r\/YM589P6\"><strong>Como o crescimento dos neg\u00f3cios da sua empresa no 2\u00ba trimestre de 2020 em rela\u00e7\u00e3o ao 2\u00ba trimestre de 2019 ser\u00e1 impactado pelas a\u00e7\u00f5es tomadas para combater a dissemina\u00e7\u00e3o do COVID-19?<\/strong><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>*********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 20 de mar\u00e7o de 2020 Copyright \u00a9 Brakke Editora de Consultoria: Lynn Fondon DVM MBA ************************************ NAS NOT\u00cdCIAS: Brakke Consulting News pesquisa de mercado Not\u00edcias sobre ganhos Kindred Biosciences Outras not\u00edcias BabelBark Dechra Destination Pet Kindred Biosciences Morgan Stanley Investment Management Omega Sea Pathway Vet Alliance Spectrum Brands Pet TSG Consumer Partners VitalPet whiskerDocs ******************* ***************** DIVULGA\u00c7\u00d5ES DE GANHOS DA EMPRESA A Kindred Biosciences, Inc. relatou resultados financeiros para o ano completo encerrado em 31 de dezembro de 2019. As receitas l\u00edquidas de produtos do ano de 2019 foram de $4,3 milh\u00f5es, em compara\u00e7\u00e3o com $2,0 milh\u00f5es no exerc\u00edcio encerrado em 31 de dezembro de 2018. Em 31 de dezembro de 2019, a KindredBio tinha $73,5 milh\u00f5es em caixa, equivalentes de caixa e investimentos, em compara\u00e7\u00e3o com $73,9 milh\u00f5es em 31 de dezembro de 2018. (empresa comunicado \u00e0 imprensa) *********************************** BRAKKE CONSULTING Insights oportunos por meio de pesquisas de mercado de resposta r\u00e1pida Com nosso banco de dados interno de veterin\u00e1rios e a capacidade de personalizar pesquisas para uma ampla variedade de p\u00fablicos-alvo, podemos fornecer informa\u00e7\u00f5es confi\u00e1veis sobre esse setor \u00fanico e obter os resultados em suas m\u00e3os rapidamente. Para mais informa\u00e7\u00f5es, consulte nosso site ou ligue para 336-396-3916. www.BrakkeConsulting.com ************************************ COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA A Kindred Biosciences, anunciou que celebrou uma transa\u00e7\u00e3o para a venda da Mirataz para a Dechra Pharmaceuticals PLC por um pagamento inicial de $43 milh\u00f5es e royalties sobre vendas mundiais. Rede registrada KindredBio<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-march-20-2020\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-27946","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-march-20-2020\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for March 20, 2020 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Brakke Consulting News market research Earnings News Kindred Biosciences Other News BabelBark Dechra Destination Pet Kindred Biosciences Morgan Stanley Investment Management Omega Sea Pathway Vet Alliance Spectrum Brands Pet TSG Consumer Partners VitalPet whiskerDocs ************************************ COMPANY EARNINGS RELEASES Kindred Biosciences, Inc. reported financial results for the full year ended December 31, 2019. Full year 2019 net product revenues were $4.3 million, compared with $2.0 million for the year ended December 31, 2018. As of December 31, 2019, KindredBio had $73.5 million in cash, cash equivalents and investments, compared to $73.9 million at December 31, 2018. (company press release) *********************************** BRAKKE CONSULTING Timely insights through rapid-turnaround market research With our in-house database of veterinarians and the ability to custom-tailor surveys of a wide variety of target audiences, we can provide you with reliable insights into this unique industry, and get the results in your hands quickly.\u00a0 For more information, see our website or call us at 336-396-3916. www.BrakkeConsulting.com ************************************ COMPANY NEWS RELEASES Kindred Biosciences, announced that it has entered into a transaction for the sale of Mirataz to Dechra Pharmaceuticals PLC for an upfront payment of $43 million and royalties on worldwide sales. KindredBio recorded netView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-march-20-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-20T01:08:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-03-20T13:03:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.20-1.jpg\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for March 20, 2020\",\"datePublished\":\"2020-03-20T01:08:22+00:00\",\"dateModified\":\"2020-03-20T13:03:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/\"},\"wordCount\":1073,\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.20-1.jpg\",\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.20-1.jpg\",\"datePublished\":\"2020-03-20T01:08:22+00:00\",\"dateModified\":\"2020-03-20T13:03:56+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#primaryimage\",\"url\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.20-1.jpg\",\"contentUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.20-1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/zh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for March 20, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-march-20-2020\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for March 20, 2020 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Brakke Consulting News market research Earnings News Kindred Biosciences Other News BabelBark Dechra Destination Pet Kindred Biosciences Morgan Stanley Investment Management Omega Sea Pathway Vet Alliance Spectrum Brands Pet TSG Consumer Partners VitalPet whiskerDocs ************************************ COMPANY EARNINGS RELEASES Kindred Biosciences, Inc. reported financial results for the full year ended December 31, 2019. Full year 2019 net product revenues were $4.3 million, compared with $2.0 million for the year ended December 31, 2018. As of December 31, 2019, KindredBio had $73.5 million in cash, cash equivalents and investments, compared to $73.9 million at December 31, 2018. (company press release) *********************************** BRAKKE CONSULTING Timely insights through rapid-turnaround market research With our in-house database of veterinarians and the ability to custom-tailor surveys of a wide variety of target audiences, we can provide you with reliable insights into this unique industry, and get the results in your hands quickly.\u00a0 For more information, see our website or call us at 336-396-3916. www.BrakkeConsulting.com ************************************ COMPANY NEWS RELEASES Kindred Biosciences, announced that it has entered into a transaction for the sale of Mirataz to Dechra Pharmaceuticals PLC for an upfront payment of $43 million and royalties on worldwide sales. KindredBio recorded netView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-march-20-2020\/","og_site_name":"Brakke Consulting Website","article_published_time":"2020-03-20T01:08:22+00:00","article_modified_time":"2020-03-20T13:03:56+00:00","og_image":[{"url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.20-1.jpg","type":"","width":"","height":""}],"author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for March 20, 2020","datePublished":"2020-03-20T01:08:22+00:00","dateModified":"2020-03-20T13:03:56+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/"},"wordCount":1073,"image":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.20-1.jpg","articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/","url":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#primaryimage"},"image":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.20-1.jpg","datePublished":"2020-03-20T01:08:22+00:00","dateModified":"2020-03-20T13:03:56+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#primaryimage","url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.20-1.jpg","contentUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.20-1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-march-20-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/zh\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for March 20, 2020"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/zh\/#website","url":"https:\/\/brakkeconsulting.com\/zh\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/27946","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=27946"}],"version-history":[{"count":6,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/27946\/revisions"}],"predecessor-version":[{"id":27962,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/27946\/revisions\/27962"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=27946"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=27946"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=27946"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}